Association Between Diabetes Mellitus and All-Cause and Cardiovascular Mortality Among Individuals With Ultrasound-Defined Non-Alcoholic Fatty Liver Disease

被引:11
作者
Wu, Weiti [1 ]
Xiang, Jingjing [2 ]
Chen, Xiaoye [3 ]
机构
[1] Taizhou Hosp, Dept Infect Dis, Taizhou, Zhejiang, Peoples R China
[2] Taizhou Hosp, Dept Emergency, Taizhou, Zhejiang, Peoples R China
[3] Taizhou Hosp, Dept Radiotherapy, Taizhou, Zhejiang, Peoples R China
来源
FRONTIERS IN ENDOCRINOLOGY | 2021年 / 12卷
关键词
non-alcoholic fatty liver disease; diabetes mellitus; NHANES; cardiovascular; mortality; HEPATIC INSULIN-RESISTANCE; NAFLD; RISK; PATHOGENESIS; MEN;
D O I
10.3389/fendo.2021.773342
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
ObjectiveThe influence of diabetes on mortality among patients with non-alcoholic fatty liver disease (NAFLD) in the general population has not been extensively studied. This study aimed to determine the relationship between diabetes and all-cause and cardiovascular mortality in patients with hepatic ultrasound-confirmed NAFLD using data from the Third National Health and Nutrition Examination Survey (NHANES III), 1988-1994. MethodsData from 4,037 adult individuals with NAFLD from the NHANES III and mortality outcomes linked to National Death Index records through December 31, 2015, were included. Cox proportional hazards models were used to calculate the hazard ratio (HR) and corresponding 95% CI for mortality from all causes and cardiovascular disease after adjusting for multiple variables. ResultsAmong 4,037 subjects with NAFLD (55.9% female), 483 had diabetes at baseline. During a median follow-up of 22.1 years, 1,517 (11.5%) died, including 332 (8.22%) from cardiovascular causes. Diabetes was associated with increased all-cause (HR 3.02 [95% CI 2.67-3.41]) and cardiovascular (HR 3.36 [95% CI 2.61-4.32]) mortality in an unadjusted multivariable Cox regression model. The association remained statistically significant after adjusting for a range of potential confounders (HR 2.20 [95% CI 1.90-2.55] for all-cause mortality and HR 2.47 [95% CI 1.81-3.37] for cardiovascular mortality). An additional stratified analysis did not reveal significantly altered results. ConclusionDiabetes was associated with all-cause and cardiovascular mortality in patients with NAFLD. This link could be further characterized in future studies assessing the degree of glycemic control and its relationship with mortality in patients with diabetes and NAFLD.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Relationship between the dynamics of non-alcoholic fatty liver disease and incident diabetes mellitus
    Han, Ji Eun
    Shin, Han-Bit
    Ahn, Young Hwan
    Cho, Hyo Jung
    Cheong, Jae Youn
    Park, Bumhee
    Kim, Soon Sun
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [22] Predictors of All-Cause Mortality and Liver-Related Mortality in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD)
    Maria Stepanova
    Nila Rafiq
    Hala Makhlouf
    Ritambhara Agrawal
    Ishmeet Kaur
    Zahra Younoszai
    Arthur McCullough
    Zachary Goodman
    Zobair M. Younossi
    Digestive Diseases and Sciences, 2013, 58 : 3017 - 3023
  • [23] Lean non-alcoholic fatty liver disease and the risk of all-cause mortality: An updated meta-analysis
    Wongtrakul, Wasit
    Charatcharoenwitthaya, Natthinee
    Charatcharoenwitthaya, Phunchai
    ANNALS OF HEPATOLOGY, 2024, 29 (03)
  • [24] Impact of diabetes on subclinical atherosclerosis and major cardiovascular events in individuals with and without non-alcoholic fatty liver disease
    Wang, Bin
    Zhao, Zhiyun
    Liu, Shanshan
    Wang, Shuangyuan
    Chen, Yuhong
    Xu, Yu
    Xu, Min
    Wang, Weiqing
    Ning, Guang
    Li, Mian
    Wang, Tiange
    Bi, Yufang
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2021, 177
  • [25] Non-alcoholic fatty liver disease and increased risk of all-cause mortality in elderly patients admitted for acute heart failure
    Valbusa, Filippo
    Agnoletti, Davide
    Scala, Luca
    Grillo, Cristina
    Arduini, Pietro
    Bonapace, Stefano
    Calabria, Stefano
    Scaturro, Giuliana
    Mantovani, Alessandro
    Zoppini, Giacomo
    Turcato, Emanuela
    Maggioni, Aldo Pietro
    Arcaro, Guido
    Targher, Giovanni
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 265 : 162 - 168
  • [26] Non-alcoholic fatty liver disease in patients with diabetes mellitus
    Naini, Sohrab Rahimi
    Fuchs, Michael
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2014, 9 (05) : 503 - 514
  • [27] Hospital admission with non-alcoholic fatty liver disease is associated with increased all-cause mortality independent of cardiovascular risk factors
    Mann, Jake P.
    Carter, Paul
    Armstrong, Matthew J.
    Abdelaziz, Hesham K.
    Uppal, Hardeep
    Patel, Billal
    Chandran, Suresh
    More, Ranjit
    Newsome, Philip N.
    Potluri, Rahul
    PLOS ONE, 2020, 15 (10):
  • [28] Association between biological aging and the risk of mortality in individuals with non-alcoholic fatty liver disease: A prospective cohort study
    Wang, Haili
    Liu, Zhenqiu
    Fan, Hong
    Guo, Chengnan
    Zhang, Xin
    Li, Yi
    Han, Xinyu
    Zhang, Tiejun
    ARCHIVES OF GERONTOLOGY AND GERIATRICS, 2024, 124
  • [29] Association of non-alcoholic fatty liver disease with cardiovascular disease and subclinical atherosclerosis
    Sao, Rahul
    Aronow, Wilbert S.
    ARCHIVES OF MEDICAL SCIENCE, 2018, 14 (06) : 1233 - 1244
  • [30] Prognostic non-invasive biomarkers for all-cause mortality in non-alcoholic fatty liver disease: A systematic review and meta-analysis
    Cianci, Nicole
    Subhani, Mohsan
    Hill, Trevor
    Khanna, Amardeep
    Zheng, Dong
    Sheth, Abhishek
    Crooks, Colin
    Aithal, Guruprasad P.
    WORLD JOURNAL OF HEPATOLOGY, 2022, 14 (05) : 1025 - 1037